Treatment of renal fibrosis

Details for Australian Patent Application No. 2002309211 (hide)

Owner Hadasit Medical Research Services and Development Ltd. State of Israel, Ministry of Agriculture, Agricultural Research Organization Collgard Biopharmaceuticals Ltd.

Inventors Nagler, Arnon; Pines, Mark; Vlodavsky, Israel; Yarkoni, Shai

Agent Freehills

Pub. Number AU-B-2002309211

PCT Number PCT/IL02/00408

PCT Pub. Number WO2002/094178

Priority 143366 24.05.01 IL

Filing date 23 May 2002

Wipo publication date 3 December 2002

Acceptance publication date 6 April 2006

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 143366 24.05.01 IL

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002309211

6 April 2006 Application Accepted

  Published as AU-B-2002309211

3 August 2006 Standard Patent Sealed

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002309212-SYSTEM AND METHOD FOR SHARING CELLULAR COMMUNICATION SERVICES AMONG MOBILE STATIONS OF DIFFERENT NETWORKS

2002309210-SUB-CARRIER GENERATION FOR OPTICAL COMMUNICATION